Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously? Marc D. PirothDavid KrugBreast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) Review Article Open access 31 July 2020 Pages: 1 - 7
R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial R. FietkauR. GrützmannD. Lubgan Original Article Open access 10 September 2020 Pages: 8 - 18
Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial—PaCa-DD-041 (Eudra-CT 2009-011968-11) Carolin ZimmermannMarius DistlerRobert Grützmann Original Article Open access 07 July 2020 Pages: 19 - 26
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro A. Allam MohamedAndreas ThomsenThomas B. Brunner Original Article Open access 23 July 2020 Pages: 27 - 38
Cardiac serum marker alterations after intraoperative radiotherapy with low-energy x-rays in early breast cancer as an indicator of possible cardiac toxicity Stefan StefanovicSebastian BerlitBenjamin Tuschy Original Article Open access 19 August 2020 Pages: 39 - 47
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial David KrugRené BaumannJürgen Dunst Original Article Open access 01 October 2020 Pages: 48 - 55
Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma Niklas Benedikt PepperMichael OertelHans Theodor Eich Original Article Open access 18 September 2020 Pages: 56 - 62
Results of a randomized controlled phase III trial: efficacy of polyphenol-containing cystus® tea mouthwash solution for the reduction of mucositis in head and neck cancer patients undergoing external beam radiotherapy Nadja EbertAnna KenscheMichael Baumann Original Article 24 September 2020 Pages: 63 - 73
The course of lung oligometastatic colorectal cancer may be a reflection of selection for treatment rather than an effect of stereotactic body radiotherapy Fergus MacbethTom Treasure Letter to the Editor 26 November 2020 Pages: 74 - 75
Reply to: The course of lung oligometastatic colorectal cancer may be a reflection of selection for treatment rather than an effect of stereotactic body radiotherapy Luca NicosiaFrancesco CucciaFilippo Alongi Letter to the Editor 26 November 2020 Pages: 76 - 78
Randomisierte Phase-IIB-Studie zur Protonentherapie vs. intensitätsmodulierte Photonentherapie für lokal fortgeschrittene Ösophaguskarzinome Mechthild Krause Literatur kommentiert Open access 30 November 2020 Pages: 79 - 81
Die lokoregionale Radiotherapie verlängert beim de novo metastasierten Nasopharynxkarzinom das Überleben signifikant Panagiotis Balermpas Literatur kommentiert 26 November 2020 Pages: 82 - 84
Neoadjuvante Radiochemotherapie verbessert bei resektablen und grenzwertig resezierbaren Pankreaskarzinomen die onkologischen Ergebnisse, bei resezierbaren aber nicht das Gesamtüberleben Robert Michael HermannHans Christiansen Literatur kommentiert Open access 30 November 2020 Pages: 85 - 88